fosun

While car sales continue to decline in China, Sequoia Capital China and Source Code Capital are betting on an increasing need for auto parts with CassTime.

The Chinese government's encouragement for autonomous driving and alternative vehicles has put pressure on traditional auto manufacturers.

Belt & Road is the new M&A catch phrase as insurers seek to appease regulators. But new traps await the unwary even in “approved” countries.

Acquisitive conglomerate launches an IPO for Israel-based Sisram Medical, a company it acquired four years ago during the early stage of China’s overseas M&A boom.

The privately-held drug maker raised $296 million from a fully-upsized placement of new H-shares, marking just the second time in nearly three years that a Hong Kong-listed company has sold new shares through a block sale.

Buying Australia’s leading health supplement brand matches Fosun’s global ambitions — and could also help the target boost its China sales.

HKEx may score a new wave of quasi-international listings as Chinese companies seek to unlock the value of European football club assets and burgeoning domestic investments.

The Hong Kong-listed company became the first Asian borrower to tap the dollar bond market in the wake of a US interest rate hike. It got a warm welcome from investors

China Oceanwide’s $2.7 billion bid for Genworth Financial continues a long line of Chinese and Japanese companies looking to snap up US insurers. Industry experts worry about regulatory snafus.